Intrinsic Value

The intrinsic value of Bellevue Group AG (BBN) under the Base Case is 5.49 CHF per share. Compared with the current market price of 6.7 CHF, the stock appears Overvalued by 18% .

The intrinsic value is calculated using the DCF method. The model assumes net margin rises from 3.6% last year to 21% by 2033, above its five-year average of 18%. If net margin stayed at its five-year average of 18%, the estimate would be about CHf6.25. The value of the years after 2033 is tied to revenue, so margins count only until then.

Do our valuations actually work? See backtest results .

BBN Intrinsic Value
CHf5.49
Overvaluation 18%
Intrinsic Value
Price CHf6.7

BBN is more expensive than usual. It was this expensive or more expensive on just 11% of days in the past 5 years.

Monitor BBN
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value CHf4.39
Get notified when the price drops into your buy zone
Current Price CHf6.7
Intrinsic Value CHf5.49
Margin of Safety 20% CHf4.39
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to BBN

Fundamental Analysis

What Bellevue Group Does

Financial Services Financials

Bellevue Group AG is a Swiss asset manager that runs investment products for institutional and private clients. Its core business is managing money through funds and mandates, with a strong focus on healthcare and other specialized equity strategies. It earns most of its money from management fees and performance-related fees tied to the assets it oversees.

Headquarters
Switzerland CH
Employees
73
IPO date
Jan 15, 2007
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Bellevue Group AG

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one BBN stock?

The intrinsic value for Bellevue Group AG (BBN) under the Base Case is 5.49 CHF.

Is BBN stock undervalued or overvalued?

Compared with the current market price of 6.7 CHF, the stock appears Overvalued by 18% .

Back to Top